Dr. Bloom welcomes dermatology questions from veterinarians and veterinary technicians.
Click here to submit your question, or send an e-mail to email@example.com
with the subject line "Dermatology questions."
Is cetirizine effective in canine allergic inhalant dermatitis, and, if so, what is the dosage?
Tom McCoy, DVM
Harvard Avenue Veterinary Clinic
Using criteria of evidence-based medicine, evidence at this time is insufficient to conclude for or against the efficacy of
any antihistamine in treating canine atopic dermatitis (a more appropriate name for what was previously known as canine allergic inhalant dermatitis since most of the antigen is percutaneously absorbed rather than inhaled). That said, strong anecdotal evidence suggests
that antihistamines do have some effect, either as a monotherapy or as a corticosteroid-sparing agent.
Paul Bloom, DVM, DACVD, DABVP
Limited studies support the efficacy of one antihistamine over another in veterinary patients. An in vitro study using canine
cutaneous mast cells and comparing the effects of loratadine, cetirizine, ketotifen, and terfenadine demonstrated that only
loratadine caused potent inhibition of histamine release from the mast cells.1 Whether this would be clinically relevant has not been studied. The only study I know of that evaluated cetirizine was a
placebo-controlled, blinded study that reported that pruritus was satisfactorily reduced in 4 of 22 (18%) dogs.2 However, only two of the four dogs had an excellent response (76% to 100% reduction), while one of the four continued to
receive a low dose of a glucocorticoid during the entire study. The fourth dog had a fair (26% to 50% reduction) response.
Treatment of canine atopic dermatitis was reviewed recently (see the Related Link "New veterinary clinical practice guidelines for canine atopy" below).3 These 2010 clinical practice guidelines recommend that if convincing clinical trial data are unavailable, veterinarians
who want to use type 1 antihistamines to treat atopy should use those that have shown demonstrable inhibitory effects after
intradermal histamine injections in dogs. At this time only hydroxyzine (2 mg/kg twice daily) and cetirizine (0.5 to 1 mg/kg
once a day) have demonstrated these effects.3 It really doesn't matter which of these two antihistamines you use since hydroxyzine is rapidly converted to cetirizine.4 The guidelines also advise that antihistamines be used preventively every day to keep H1 receptors inactive so histamine
is not released during immediate allergic reactions.
So cetirizine may be effective in some dogs with atopic dermatitis, but it is not one of the antihistamines that I prescribe
for my patients. I don't see an advantage of this antihistamine over the traditional ones (diphenhydramine, hydroxyzine, chlorpheniramine).
Because many different antihistamines are available and none is more effective than another, I suggest you choose an antihistamine
based on ease of administration (pill vs. capsule, twice vs. three times a day), cost, and side effects. If after 14 days
the dog shows no improvement, prescribe another antihistamine until each of the antihistamines has been tried for 14 days
or an effective one has been found.
Paul Bloom, DVM, DACVD, DABVP
Allergy, Skin and Ear Clinic for Pets
31205 Five Mile
Livonia, MI 48154
1. Garcia G, DeMora F, Ferrer L, et al. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast
cells. Am J Vet Res 1997;58(3):293-297.
2. Cook CP, Scott DW, Miller WH Jr, et al. Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine:
a single-blinded, placebo-controlled study. Can Vet J 2004;45(5):414-417.
3. Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the
International Task Force on Canine Atopic Dermatitis. Vet Dermatol 2010;21(3):233-248.
4. Bizikova P, Papich MG, Olivry T. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous
administration of hydroxyzine to healthy dogs. Vet Dermatol 2008;19:348-357.